Claims Dismissed in Insurer Class Action
Client Alert | less than 1 min read | 04.09.07
On April 9, 2007, Judge Garret E. Brown of the U.S. District Court for the District of New Jersey dismissed bid-rigging claims brought against Marsh & McLennan Cos. Inc. and several other insurance brokers and providers in a long-running, multidistrict class action lawsuit. The judge dismissed all of the plaintiffs' claims without prejudice, finding that they had not submitted enough evidence to prove that the alleged conspiracies between insurance companies and brokers were illegal. The plaintiffs alleged the defendants participated in broker-centered conspiracies that aimed to allocate customers and reduce competition. The plaintiffs alleged that the conspiracies date back to the mid-1990’s, when insurance brokers consolidated their markets.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
